We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Benjamin Lowentritt

Benjamin Lowentritt MD

Director of Prostate Cancer Services, United Urology

Dr. Benjamin Lowentritt was named Director of Prostate Cancer Services for United Urology in 2018 after serving as the Director of Prostate Cancer Care Program and Director, Minimally invasive Surgery and Robotics at Chesapeake Urology, a member of United Urology’s group practices. Dr. Lowentritt is a member of United Urology’s Executive Clinical Team.

As Director, Dr. Lowentritt is responsible for working with member practices to build and optimize services for prostate cancer patients.  This includes supporting physicians, staff, and operational teams treatment options are expanded.  The goal is for each member group to have a comprehensive, state-of-the-art program that helps patients through a difficult diagnosis.

Dr. Lowentritt has been at the forefront of robotic urology procedures and was the first surgeon in Maryland to perform robot-assisted surgery for bladder cancer. He has authored numerous articles on robotic surgery, erectile dysfunction, pediatric urology, female urology and the urological management of patients after renal transplantation.

He received his Doctor of Medicine degree from Baylor College of Medicine, completed his medical residency at the University of Maryland School of Medicine and a fellowship in Robotic, Laparoscopic and Endoscopic Urology at Tulane University. Dr. Lowentritt has served on the board of the Mid-Atlantic Section of the American Urological Association and is currently serving as President-Elect. He also serves on the Boards of Directors for MedChi, the Maryland State Medical Society, and the Baltimore City Medical Society, including as a past President. He has been recognized as a Top Doctor in multiple publications over multiple years and selected as a “Super Doctor” by his peers in The Washington Post.

Recent Contributions to PracticeUpdate:

  1. The Impact of COVID-19 on the Business of Urology